The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

Mark Nelson, Christine Katlama, David A. Cooper, Brian Gazzard, Bonaventura Clotet, Adriano Lazzarin, Knud Schewe, Joep M. A. Lange, Christina Wyatt, Sue Curtis,

AIDS · 2007 · 348 citations · 28 references

Abstract

The data demonstrate a favorable safety profile for tenofovir DF in the treatment of adults with HIV infection. Risk factors for development of nephrotoxicity can be identified and may be useful in managing those patients at greatest risk.

References

28